NCT07742683

Brief Summary

This study addresses the shortcomings of routine clinical management for tuberculosis (TB) patients by proposing psychosocial interventions targeting stigma, while investigating the current status of stigma, psychological issues, medication adherence, and drug resistance among tuberculosis patients. It analyzes the underlying mechanisms, integrates online mindfulness courses, digital cognitive behavioral therapy (CBT), and human-machine interactive dialogue modules to develop a digital psychosocial intervention platform. Through a randomized controlled trial, the study validates the impact of the platform on stigma and health outcomes among tuberculosis patients in China. Ultimately, the research aims to formulate a scalable digital psychosocial intervention technical solution, providing evidence-based support for optimizing China's comprehensive tuberculosis prevention and control model.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
496

participants targeted

Target at P75+ for not_applicable

Timeline
26mo left

Started Oct 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 3, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

August 3, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

July 27, 2026

Last Update Submit

July 29, 2026

Conditions

Keywords

TuberculosisDigital Psychosocial InterventionsStigmaOnline Mindfulness CoursesCognitive Behavioral TherapyHuman-computer Interaction

Outcome Measures

Primary Outcomes (1)

  • Stigma: Tuberculosis-related Stigma Scale (TSS)

    The tuberculosis-related stigma scale (TSS) was adopted in this study to quantitatively assess the level of tuberculosis-related stigma among participants.The scale consists of 9 items in total with a total score range of 0 to 27 points. Higher scores on the TSS indicate a more severe level of tuberculosis-related stigma.

    Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention

Secondary Outcomes (3)

  • Mental Health, such as depression (Patient Health Questionnaire, PHQ-9)and anxiety (Generalized Anxiety Disorder Questionnaire, GAD-7)

    Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention

  • Health outcomes, such as sputum conversion rate and quality of life (EuroQol 5 Dimensions,EQ-5D)

    Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention

  • Medication Adherence (8-item Morisky Medication Adherence Scale, MMAS-8)

    Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention

Other Outcomes (1)

  • Intervention adherence and acceptability

    Baseline, Post-Intervention, 3-month Post-Intervention, 6-month Post-Intervention, 1-year Post-Intervention

Study Arms (4)

Online Mindfulness Intervention Group

EXPERIMENTAL

Participants in this group received a 6-week online mindfulness course delivered twice weekly.

Behavioral: Online Mindfulness

Online CBT Intervention Group

EXPERIMENTAL

Participants in this group received a 6-week online CBT intervention course delivered twice weekly.

Behavioral: Online CBT Intervention

Human-computer Interaction Intervention Group

EXPERIMENTAL

The patients in this group are required to use the human-computer interaction system developed by our research institute for a duration of 6 weeks, with a frequency of no less than 2 use per week and a duration of no less than 20 minutes per use.

Behavioral: Human-computer Interaction

Control Group

ACTIVE COMPARATOR

Patients in the control group continued to receive routine treatment and management services provided by the tuberculosis prevention and control system throughout the study period. No additional psychosocial services or digital health services were offered beyond routine psychological support.

Behavioral: Routine treatment and management services provided by the tuberculosis prevention and control system

Interventions

The 6-week online mindfulness course developed by our research team consists of theoretical lectures plus practice audio and video materials, with 2 sessions delivered per week.

Online Mindfulness Intervention Group

The 6-week online cbt course developed by our research team consists of 12 video materials, with 2 sessions delivered per week.

Online CBT Intervention Group

The human-computer interaction mini-program named Xiexin Xiangban, developed by the research team.

Human-computer Interaction Intervention Group

routine treatment and management services provided by the tuberculosis prevention and control system

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older.
  • Patients diagnosed with active pulmonary tuberculosis within the past 1 year via bacteriological tests (smear microscopy or culture) and/or molecular biological assays (e.g., GeneXpert).
  • Capable of independently completing questionnaires and scale assessments; accessible for sputum collection, chest radiography, biomarker testing and other examinations.
  • Provided full informed consent for the entire study and signed the written informed consent form.

You may not qualify if:

  • Presence of severe chronic diseases such as immune system disorders, or severe neurological and psychiatric disorders.
  • No access to electronic devices required for subsequent online intervention.
  • Cognitive impairment or hearing loss that impairs normal communication and prevents cooperation with surveys and intervention procedures.
  • Concurrent participation in other health promotion or clinical intervention studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

TuberculosisSocial Stigma

Condition Hierarchy (Ancestors)

Mycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsSocial BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D. candidate

Study Record Dates

First Submitted

July 27, 2026

First Posted

August 3, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

December 1, 2028

Last Updated

August 3, 2026

Record last verified: 2026-04